Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidex Otic Solution in Acute Otitis Media with Tympanostomy Tubes
2009-017319-13Phase 3
- Sponsor
- Alcon Inc.
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of moxifloxacin + dexamethasone in acute otitis media (AOM), sponsored by Alcon Inc. Primary endpoint: Clinical cure rate at Day 8 (end of therapy).
02
Drugs
moxifloxacin + dexamethasone
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on 2009-017319-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017319-13.